Labcorp Plasma Detect defines a tumor-informed MRD signature using WGS of tumor DNA, germline DNA from buffy coat and cell-free DNA collected at the landmark time point. These data are analyzed with a proprietary machine learning algorithm to identify thousands of high-confidence, patient-specific somatic tissue variants, creating a signature that can be tracked over time to determine the ctDNA status.